ByMyCell
Ribeirão Prêto
About ByMyCell
By My Cell provides sequencing services for the small plant, fungus, and bacterial genomes. They sequence the client's genomic DNA using an Illumina platform, and they also provide third-generation sequencing using an Oxford Nanopore platform with long articles. Additionally, they provide a hybrid genome assembly service that creates genomes by combining short and long reads. Our platform ByMySoill is dedicated to microbiota analysis for precision agriculture and help farms to identify potential and threats in their fields, allowing them to reduce production costs by using precise bioinputs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $222.7K
- Last round: Grant (Aug 2023)
- Website: bymycell.com.br
- Phone: +55 -11-98848-1438
Industries & Categories
Agriculture, Bioinformatics, Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/bymycell-193604 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.